On this page
The research desk’s view
The MOTS-c page describes a one-time prescription consultation and separate pharmacy quote. $118 visit, or $55 for eligible members; medication/labs/later visits separate unless listed.
The listing, in detail
- Published service
- Clinician-coordination platform; independent pharmacy fulfillment if prescribed and available
- Product/menu scope
- The MOTS-c page describes a one-time prescription consultation and separate pharmacy quote.
- Cost position
- $118 visit, or $55 for eligible members; medication/labs/later visits separate unless listed
- Decision condition
- Confirm exact product, individual eligibility and complete quote before a payment commitment
What the listing establishes
- The MOTS-c page describes a one-time prescription consultation and separate pharmacy quote.
- $118 visit, or $55 for eligible members; medication/labs/later visits separate unless listed
What it leaves unanswered
- The ordinary and member visit fees should not be compared without the membership prerequisite. The company is Eden Telemed, not automatically the same operator as another business using Eden branding. Its own care and pharmacy terms need independent confirmation.
- A provider listing does not establish individual eligibility or a clinical benefit.
The offer in its own setting
Eden Telemed enters this comparison through a specific public listing: the MOTS-c page describes a one-time prescription consultation and separate pharmacy quote. The service describes clinician-coordination platform; independent pharmacy fulfillment if prescribed and available. That gives a reader a real place to begin asking questions, while leaving the clinical decision individual. It does not independently verify the pharmacy, establish that the product is appropriate or promise access. The starting evidence guide is useful background because the body's own MOTS-c signal and an administered product answer different research questions.
What deserves a second look
The ordinary and member visit fees should not be compared without the membership prerequisite. The company is Eden Telemed, not automatically the same operator as another business using Eden branding. Its own care and pharmacy terms need independent confirmation.
What the number does and does not mean
The public cost position is: $118 visit, or $55 for eligible members; medication/labs/later visits separate unless listed. The written-quote comparison separates a medication amount from the costs of the wider care relationship.
Keep the biology separate from the promise
The distinction becomes clearer in the linked research appraisal. Its setting was aged human placenta-derived mesenchymal stem cells, and the outcomes concerned cell morphology, mitochondrial state, oxidant measures and lipid synthesis. Human-derived cells are not a whole human intervention or evidence of renewed organ function. That observation helps a reader ask a narrower question of Eden Telemed: which human outcome evidence supports the exact proposal? A scientific reason for interest is not a forecast of a personal response, and a convenient care pathway does not turn the experimental system into a patient treatment trial.
A different way to arrange care
For another service model, read the next provider comparison, which concerns midland clinic with ordering, later clinic pickup and instructions. The point is to compare the care arrangement and remaining questions, not imply the same product or endorse a clinical outcome. A service with a clearer price can still have unresolved clinical suitability; a consultation with no product guarantee can still provide useful assessment. We have not measured patient experience, support speed or the quality of a supplied preparation at either service.
Read the source
Research findings and provider statements are different evidence.
- Eden Telemed official product or clinical-service pageCompany website